SYMPHONY
SYMPHONY LIMITED
Each stock's 10,000-path forecast, rendered as light.
SYMPHONY LIMITED (SYMPHONY) Stock Analysis & Case Study
Is SYMPHONY a good buy? The data-driven verdict.
SYMPHONY LIMITED (SYMPHONY) trades at ₹652,on the numbers it tread carefully, a Downstox Snapshot Score of 37/100.
On the numbers, SYMPHONY LIMITED (SYMPHONY) tread carefully, a Downstox Snapshot Score of 37/100, weighing expensive at 1151.0× earnings, ROE of 3.0%, a 52% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
SYMPHONY fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How SYMPHONY ranks against the 2,373 companies in our screener
- SYMPHONY's market cap of 4,491 Cr ranks in the 64th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- SYMPHONY's book value of ₹79 ranks in the 45th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- SYMPHONY's promoter holding of 73.4% ranks in the 84th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- SYMPHONY's 3-year profit (PAT) growth of -45.0% ranks in the bottom 3% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- SYMPHONY's 3-year revenue growth of -2.0% ranks in the 20th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- SYMPHONY's debt-to-equity ratio of 0.32x is lower than 49% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
Is SYMPHONY overvalued? SYMPHONY P/E vs peers
SYMPHONY trades at 1151.0× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
SYMPHONY share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 9.8y of SYMPHONY history (-6%/yr drift, 37%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| SYMPHONY 2027 | ₹417 | ₹667 | ₹1,068 | +2% |
| SYMPHONY 2028 | ₹351 | ₹681 | ₹1,323 | +4% |
| SYMPHONY 2029 | ₹305 | ₹695 | ₹1,580 | +6% |
| SYMPHONY 2030 | ₹275 | ₹709 | ₹1,829 | +8% |
| SYMPHONY 2031 | ₹249 | ₹723 | ₹2,102 | +11% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability SYMPHONY goes up, or doubles?
The bull case for SYMPHONY
- SYMPHONY's return on capital employed of 20.6% ranks in the 81st percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹1,580.
The bear case & risks
- SYMPHONY's P/E of 1155.0x is lower than 1% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- A steep 8.2× price-to-book means most of the value is intangible/expectations, not assets on the books.
- SYMPHONY's return on equity of 3.0% ranks in the 23rd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹305.
SYMPHONY volatility & expected range, how bumpy is the ride?
Over the last 9.8 years SYMPHONY compounded at -6%/year with annualized volatility of 37%. That volatility implies a 1-year 80% range of ₹417-₹1,068, the honest backbone behind any single price target.
SYMPHONY price forecast, the full 60-month probability fan
SYMPHONY price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds SYMPHONY hits common targets within the simulated horizon?
Full multi-horizon detail on the SYMPHONY price target & forecast page.
SYMPHONY Piotroski F-Score: 4/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. SYMPHONY scores 4/8, mixed financial health.
SYMPHONY MTF margin & leverage across 10 brokers
Margin Trading Facility lets you buy SYMPHONY with part of the capital. Lower margin % = higher leverage. Rates compared across 10 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 35.00% | 2.9× |
| Zerodha | 30.72% | 3.3× |
| Groww | 30.78% | 3.2× |
| Dhan | 30.72% | 3.3× |
| Kotak Neo | 34.97% | 2.9× |
| Paytm Money | 40.76% | 2.5× |
| Pocketful | 31.04% | 3.2× |
| Anand Rathi | 30.72% | 3.3× |
| Bajaj Broking | 33.00% | 3.0× |
| Share IndiaCHEAPEST | 30.69% | 3.3× |
Compare every broker on the SYMPHONY MTF page.
About SYMPHONY LIMITED: sector, index & market-cap context
SYMPHONY LIMITED (SYMPHONY) is a small-cap NSE-listed company, with a market capitalisation of ₹4,476 Cr. See more stocks on our screener.
How the SYMPHONY Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of SYMPHONY LIMITED's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
SYMPHONY analysis, FAQs
Is SYMPHONY LIMITED (SYMPHONY) a good buy?
On the numbers, SYMPHONY LIMITED (SYMPHONY) tread carefully, a Downstox Snapshot Score of 37/100, weighing expensive at 1151.0× earnings, ROE of 3.0%, a 52% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is SYMPHONY overvalued or undervalued?
SYMPHONY trades at 1151.0× earnings, expensive versus the ~22× long-run Nifty average.
What is the SYMPHONY share price target for 2031?
SYMPHONY's probability-weighted 2031 median target is ₹723, with an 80% range of ₹249-₹2,102 (10,000-path Monte-Carlo).
What is the probability SYMPHONY doubles in 5 years?
The modelled probability of SYMPHONY reaching ₹1,308 (2×) within 5 years is 23%.
What is the bull case for SYMPHONY?
SYMPHONY's return on capital employed of 20.6% ranks in the 81st percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
What are the risks in SYMPHONY?
SYMPHONY's P/E of 1155.0x is lower than 1% of the 2,373 NSE companies in our screener, as of 9 Aug 2026. A steep 8.2× price-to-book means most of the value is intangible/expectations, not assets on the books. SYMPHONY's return on equity of 3.0% ranks in the 23rd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.